Suppr超能文献

[骨关节炎疾病:昔康衍生物疗法]

[Osteoarthritic disease: therapy with oxicam derivatives].

作者信息

Abate G, Zito M, Guarino F, Di Peppe M C, Troya C

机构信息

Istituto di Fisiopatologia Medica, Cattedra di Geriatria, Università degli Studi G. D'Annunzio, Chieti.

出版信息

Riv Eur Sci Med Farmacol. 1990 Aug-Oct;12(4-5):273-81.

PMID:2103968
Abstract

Two groups, each composed of 20 elderly patients suffering from osteoarthritis characterised by intense pain, were treated for 4 weeks with the oral formulation of two modern oxicam derivatives (tenoxicam capsules and beta-cyclodextrin-piroxicam tablets respectively). The analysis of the results showed that both drugs have an excellent antalgic effect. After the first dose the action of beta-cyclodextrin-piroxican was quicker and more marked, with statistically significant differences between treatments for the first 4 hours. At the end of the study period the two drugs proved to be equally effective, with a more pronounced symptomatic effect of beta-cyclodextrin-piroxican. No side effects serious enough to warrant suspension of treatment were observed: the only side effects reported were gastric adverse events (pyrosis, gastralgia) in both groups, having an incidence of 50% (tenoxicam) and 15% (beta-cyclodextrin-piroxicam) respectively.

摘要

两组,每组由20名患有以剧痛为特征的骨关节炎的老年患者组成,分别用两种现代奥昔康衍生物的口服制剂(替诺昔康胶囊和β-环糊精吡罗昔康片)治疗4周。结果分析表明,两种药物均具有出色的镇痛效果。首次给药后,β-环糊精吡罗昔康的作用起效更快且更显著,在最初4小时内治疗之间存在统计学显著差异。在研究期结束时,两种药物被证明同样有效,β-环糊精吡罗昔康的症状改善效果更明显。未观察到严重到足以导致停药的副作用:报告的唯一副作用是两组的胃部不良事件(烧心、胃痛),发生率分别为50%(替诺昔康)和15%(β-环糊精吡罗昔康)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验